Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
80°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verve Therapeutics Inc
(NQ:
VERV
)
4.940
+0.100 (+2.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Verve Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
February 12, 2024
It's less scary to take on risky investments when the market is rising.
Via
The Motley Fool
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential
January 31, 2024
Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics, for example.
Via
InvestorPlace
Why Beam Therapeutics Stock Zoomed 17% Higher Today
January 29, 2024
JPMorgan Chase becomes the latest institution in the company's bull pen.
Via
The Motley Fool
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks.
Via
InvestorPlace
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains.
Via
InvestorPlace
Why Verve Therapeutics Stock Crashed as Much as 30% This Week
November 17, 2023
There was a concerning development in the company's clinical trials.
Via
The Motley Fool
After Its Stock Crashed 42% in 1 Day, Is Verve Therapeutics a Buy?
November 16, 2023
It reported some very bad news, but the market might be overreacting.
Via
The Motley Fool
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
December 31, 2023
Curing rare inherited illnesses could be a lucrative business model.
Via
The Motley Fool
$18M Bet On Verve Therapeutics? Check Out These 3 Stocks Insiders Are Buying
December 06, 2023
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
Via
Benzinga
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
Via
The Motley Fool
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 29, 2023
Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS...
Via
Benzinga
Why Verve Therapeutics Stock (VERV) Is Falling
November 29, 2023
Verve Therapeutics Inc (NASDAQ: VERV) shares are trading lower by 6.3% to $11.18 Wednesday morning after the company priced its proposed public offering of common stock and
Via
Benzinga
Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
November 29, 2023
Shares of Workday, Inc. (NASDAQ: WDAY) surged in pre-market trading after the company reported upbeat earnings results for its third quarter.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 29, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 29, 2023
Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning!
Via
InvestorPlace
Leslie's Posts Weak Earnings, Joins Las Vegas Sands, Verve Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
November 29, 2023
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining around 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 28, 2023
Via
Benzinga
Verve Therapeutics: Why Great Results Aren't Enough
November 16, 2023
The company's twist on CRISPR appears to work as intended but that didn't stop this biotech's stock price from collapsing.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 14, 2023
Via
Benzinga
Crude Oil Gains Over 1%; US Budget Deficit Narrows For October
November 13, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 50 points on Monday. The Dow traded up 0.16% to 34,337.33 while the NASDAQ fell 0.11% to 13,783.41. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 13, 2023
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 13, 2023
Via
Benzinga
These 2 Stocks Are Making Big Monday Moves
November 13, 2023
Find out what's getting investors' attention in today's session.
Via
The Motley Fool
Dow Surges 100 Points; Tenax Therapeutics Shares Spike Higher
November 13, 2023
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining around 100 points on Monday. The Dow traded up 0.33% to 34,397 while the NASDAQ fell 0.06% to 13,790. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Verve Loses A Third Of Its Value As Safety Concerns Plague Its Gene-Editing Drug
November 13, 2023
Patients had big decreases in LDL cholesterol. But there were some side effects.
Via
Investor's Business Daily
JOBY Stock Alert: Joby Aviation Scores New Tax Credit for Ohio Factory
November 13, 2023
Joby Aviation stock is getting a boost on Monday as investors in the company react to a new tax credit offer to build a factory in Ohio.
Via
InvestorPlace
US Stocks Fall; Tyson Foods Posts Upbeat Earnings
November 13, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.08% to 34,254.53 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Verve Therapeutic Provides First Look At Gene-Editing Drug For Inherited High 'Bad' Cholesterol, Shares Fall
November 13, 2023
Verve Therapeutics Inc (NASDAQ: VERV) released the first human proof-of-concept data for in vivo base editing from the ongoing heart-1 phase 1b trial of VERVE-101 from the
Via
Benzinga
Why Is Tracon Pharmaceuticals (TCON) Stock Down 22% Today?
November 13, 2023
Tracon Pharmaceuticals stock is falling on Monday as the company's shares give up their gains from an earnings rally on Friday.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.